<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/onswik-weekly-insulin-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T18:16:57-04:00</news:publication_date>
      <news:title>FDA Approves Onswik, Lilly&apos;s Once-Weekly Basal Insulin</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/vitruvias-thyroid-tablets-class-i-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T18:05:50-04:00</news:publication_date>
      <news:title>FDA Recalls Vitruvias Thyroid Tablets Over Superpotency</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/winrevair-early-pah-treatment-window</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T18:05:50-04:00</news:publication_date>
      <news:title>FDA Label Now Backs Early Winrevair Use in PAH</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/incyte-povofortay-chmp-opinion</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T09:26:29-04:00</news:publication_date>
      <news:title>Incyte Lands EU Backing for First Oral HS Pill</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/marani-health-mcare-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T09:26:29-04:00</news:publication_date>
      <news:title>Marani Health Clears FDA for M•care Fetal Monitor</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/rhythm-imcivree-health-canada-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T09:26:29-04:00</news:publication_date>
      <news:title>Rhythm Expands IMCIVREE to Acquired Obesity in Canada</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/getinge-intergard-vascular-graft-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T05:57:47-04:00</news:publication_date>
      <news:title>France Pulls Getinge Vascular Grafts Over Yarn Defect</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/heidi-overton-fda-nominee-senate-hearing</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T05:57:47-04:00</news:publication_date>
      <news:title>FDA Nominee Overton Grilled on Mifepristone, Vaccines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/sanofi-insulin-sarclisa-cold-chain-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27T05:57:47-04:00</news:publication_date>
      <news:title>Sanofi Recalls Insulin Pens, Sarclisa Over Cold Chain</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/biolinq-shine-otc-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T09:30:29-04:00</news:publication_date>
      <news:title>Biolinq&apos;s Shine Clears FDA for OTC Sale</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mirum-atebrioz-fop-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T09:30:29-04:00</news:publication_date>
      <news:title>Mirum Wins FDA Nod for Third FOP Drug Atebrioz</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/precision-neuroscience-series-d-financing</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T09:30:29-04:00</news:publication_date>
      <news:title>Precision Neuroscience Raises $250M for BCI</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-robotic-surgery-draft-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T05:57:37-04:00</news:publication_date>
      <news:title>FDA Drafts First Guidance for Surgical Robots</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/merck-welireg-lenvima-ccrcc-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T05:57:37-04:00</news:publication_date>
      <news:title>FDA Clears Welireg-Lenvima Combo for Kidney Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/nezglyal-leriglitazone-cald-ec-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-26T05:57:37-04:00</news:publication_date>
      <news:title>EU Approves First Drug for Cerebral ALD</news:title>
    </news:news>
  </url>
</urlset>
